アジア太平洋地域におけるがん光線力学療法市場の規模、シェア、動向分析レポート
Market Size in USD Billion
CAGR :
% 
USD
738.34 Million
USD
1,383.02 Million
2024
2032
 予測期間 |
2025 –2032 |
 市場規模（基準年） |
USD 738.34 Million |
 Market Size (Forecast Year) |
USD 1,383.02 Million |
 CAGR |
% |
| Major Markets Players |
|
アジア太平洋がん光線力学療法市場：製品タイプ別（光感受性薬、光線力学療法機器、付属品・消耗品）、がん適応症別（皮膚・皮膚腫瘍、頭頸部、食道、肺、膀胱、頸部、前立腺）、治療法別（単独療法、補助療法、緩和療法、併用療法、その他）、治療技術別（体外照射、組織内照射、腔内照射、術中照射、その他）、病期別（早期がん、後期がん）、患者属性別（小児、成人、高齢者）、エンドユーザー別（病院、皮膚科・皮膚がんクリニック、外来手術センター、学術研究機関、その他）、流通チャネル別（直接入札、サードパーティ販売業者、オンライン、その他） - 業界動向と2025年までの予測2032年。
アジア太平洋地域のがん光線力学療法市場規模
- アジア太平洋地域のがん光線力学療法市場は、2024年に7億3,834万米ドルと評価され、予測期間中に8.3%のCAGRで成長し、2032年には13億8,302万米ドルに達すると予想されています。
- 市場は主に、がん罹患率の上昇、医療費の増加、そして先進的な治療法への意識の高まりによって牽引されています。医療インフラの急速な改善、専門がん治療センターの拡大などにより、
- この成長は、早期診断と革新的な治療法を促進する政府の取り組み、大規模な患者プール、光線力学療法技術への国際企業と地元企業による投資の増加などの要因によって推進されています。
アジア太平洋地域におけるがん光線力学療法市場分析
- がん光線力学療法（PDT）市場は、がん罹患率の増加、非侵襲的治療への意識の高まり、光感受性薬やレーザー技術の進歩により、着実に成長しています。
- 新興市場では、政府の取り組み、医療費の増加、そして高齢化人口の増加を背景に、PDTの導入が急速に進んでいます。しかし、治療費の高騰と限られた償還が依然として大きな制約となっています。一方で、併用療法や標的光感受性剤の継続的な革新は、大きな成長機会をもたらしています。
- 中国は、膨大な患者数、がん罹患率の増加、そして医療費の増加に支えられ、2025年にはアジア太平洋地域のがん光線力学療法市場において43.73%という最大の収益シェアを獲得し、市場を席巻すると予想されています。先進がん治療に対する政府の強力な支援、革新的な治療法の導入拡大、そして主要な国内PDT機器メーカーの存在などがその背景にあります。
- 日本は、がん罹患率の上昇、高度な医療インフラ、そして革新的な治療法に対する強力な政府支援に支えられ、予測期間中にアジア太平洋地域のがん光線力学療法市場において8.9%のCAGRで最速の成長を遂げると予想されています。患者と医師の意識の高まりと、低侵襲療法の導入が相まって、需要が高まっています。
- 光増感剤セグメントは、2025年に76.15%の市場シェアでアジア太平洋がん光線力学療法市場を支配すると予想されており、これは、さまざまながんに対する光線力学療法の採用の増加、新規光増感剤の承認の増加、および地域全体での低侵襲治療オプションの選好の増加によるものです。
レポートの範囲とアジア太平洋地域のがん光線力学療法市場のセグメンテーション
|
属性 |
アジア太平洋地域のシルク主要市場分析 |
|
対象セグメント |
|
|
対象国 |
アジア太平洋
|
|
主要な市場プレーヤー |
|
|
市場機会 |
|
|
付加価値データ情報セット |
データブリッジマーケットリサーチがまとめた市場レポートには、市場価値、成長率、セグメンテーション、地理的範囲、主要プレーヤーなどの市場シナリオに関する洞察に加えて、輸出入分析、生産能力概要、生産消費分析、価格動向分析、気候変動シナリオ、サプライチェーン分析、バリューチェーン分析、原材料/消耗品概要、ベンダー選択基準、PESTLE分析、ポーター分析、規制枠組みも含まれています。 |
アジア太平洋地域のがん光線力学療法市場動向
「他のがん治療との統合」
- 光線力学療法（PDT）は、免疫反応を刺激しながら局所的に腫瘍細胞を死滅させる能力があり、マルチモーダル癌治療の魅力的なパートナーとして位置づけられています。
- PDT によって腫瘍抗原の放出が増加し、腫瘍微小環境が調整され、免疫細胞の浸潤や活性化が促進されるという証拠が増えています。これらのメカニズムは、免疫チェックポイント阻害剤、治療用癌ワクチン、化学療法、放射線療法と相乗効果を発揮する可能性があります。
- PDT と全身療法を組み合わせることで、局所制御を永続的な全身反応に変換し、毒性物質の投与量を減らすことができ、適応症（切除不能または転移性疾患など）を拡大することができます。
- 臨床研究とトランスレーショナルリサーチが増加するにつれて、他のモダリティとの統合はPDTの臨床的意義と商業的普及を拡大するための価値の高い道筋となる。
アジア太平洋地域のがん光線力学療法市場の動向
ドライバ
「がんの罹患率の増加」
- 世界中でがんの罹患率が増加していることは、光線力学療法（PDT）などの治療法の需要を高める最大の要因の 1 つです。
- 人口が増加し高齢化し、診断ツールが改良されるにつれて、毎年より多くの癌症例が検出されるようになっています。
- 低所得国および中所得国では、喫煙、肥満、運動不足、大気汚染、感染症などの危険因子の割合が高いことも、発症率の上昇に寄与しています。
- 効果的で、侵襲性が低く、費用効率の高い局所治療法を必要とする患者が増えるにつれて、PDT はより魅力的になります。
- がんの負担の増加は医療システムに負担をかけ、治療成績を改善し、副作用を減らし、より広く展開できる治療法に対する緊急の圧力を生み出している。
抑制/挑戦
「光の浸透深度の制限」
- 光線力学療法のより広範な採用と有効性を妨げる大きな制約は、活性化光が人間の組織に浸透しにくいことです。
- 光感受性剤は特定の波長の光によって活性化される必要があるため、組織による光の吸収と散乱により、光が届く深さが減少します。
- 可視光 PS は、表面にある腫瘍やアクセスしやすい腫瘍にのみ有効であることが多く、より深い腫瘍や大きな腫瘍の場合は困難が残ります。
- この制限により、腫瘍の破壊が不完全となり、侵襲的な光照射（ファイバープローブ、内視鏡検査など）が必要となり、手順の複雑さが増し、結果が悪かったり再発したりする可能性があります。
- これを克服する画期的な進歩がない限り、PDTは非侵襲的かつ効果的に治療できる癌の範囲が制限されたままである。
アジア太平洋地域のがん光線力学療法市場の範囲
市場は、製品タイプ、がんの適応症、治療法、処置技術、病気の段階、患者の人口統計、エンドユーザー、流通チャネルに基づいてセグメント化されています。
- 製品タイプ別
アジア太平洋地域のがん光線力学療法市場は、製品タイプ別に、光感受性薬剤と光線力学療法機器に分類されます。2025年には、治療効果における重要な役割、がん種全体への幅広い適用性、そして多様な製剤（静脈内、局所、経口、膀胱内、腹腔内）により、光感受性薬剤セグメントが75.38%の市場シェアを獲得し、市場を席巻すると予想されています。この市場シェア拡大を牽引する主な要因としては、がん罹患率の上昇、低侵襲療法の導入拡大、継続的な医薬品イノベーション、そして規制当局の承認などが挙げられ、これらが相まって光感受性薬剤はPDT機器を凌駕する主要な収益源となっています。
アジア太平洋地域のがん光線力学療法市場において、光増感剤（PDT）は最も急成長している分野であり、年平均成長率（CAGR）は6.8%と最も高くなっています。これは、標的治療および低侵襲がん治療の導入拡大によるものです。PDTの有効性に対する認知度の高まり、従来の治療法に比べて副作用が少ないこと、そして腫瘍選択性が向上し組織深部への浸透性も向上した次世代光増感剤の開発が、PDTの需要を牽引しています。さらに、新規光増感剤の臨床研究と承認取得が市場拡大を後押ししています。
- がんの兆候別
アジア太平洋地域のがん光線力学療法市場は、がんの適応症に基づいて、皮膚・皮膚腫瘍、頭頸部、食道、肺、膀胱、子宮頸部、および前立腺に分類されます。2025年には、皮膚・皮膚腫瘍が、皮膚がんの有病率の高さ、早期発見の認知度の高さ、そして優れた美容効果を実現するPDTの有効性により、52.59%の市場シェアで市場を席巻すると予想されています。このセグメントは、特に最大の患者層である高齢者および成人患者において、光感受性薬およびPDT機器の幅広い導入の恩恵を受けています。さらに、日光角化症、基底細胞がん、および扁平上皮がんに対する低侵襲性標的療法の需要の高まりと、主要地域における有利な償還政策により、他のがん適応症に対する市場リーダーシップがさらに強化されています。
アジア太平洋地域のがん光線力学療法市場において、皮膚・皮膚腫瘍学分野は、皮膚がんの罹患率の増加、早期診断への意識の高まり、そして副作用の少ない低侵襲治療への関心の高まりにより、年平均成長率7.3%と最も高い成長率を記録しています。光線力学療法は、標的への作用、迅速な回復、そして美容上の成果の向上を特徴としており、皮膚腫瘍学において非常に魅力的な治療法となっています。さらに、光感受性剤および光照射システムの技術進歩も、この分野における普及を促進しています。
- 治療法別
アジア太平洋地域のがん光線力学療法市場は、治療様式に基づいて、単独療法、補助療法、緩和療法、その他に分類されます。2025年には、皮膚がん、食道がん、肺がんなどの局所がんの一次治療としての有効性により、単独療法セグメントが41.67%の市場シェアで市場を席巻すると予想されています。この優位性を推進する主な要因としては、高い有効性、低侵襲性、優れた美容効果、標的療法に対する臨床的選好の高まりなどが挙げられます。地域別では、高度な医療インフラ、確立された償還枠組み、高い患者認知度により、アジア太平洋地域が単独PDTの導入をリードしています。一方、アジア太平洋地域の新興市場では、がん罹患率の上昇、病院ネットワークの拡大、最新の腫瘍治療へのアクセス向上を背景に、導入が増加しています。こうした地域的な動向に加え、PDTの利点に関する教育と認知度の高まりが相まって、世界的に単独療法の優位性を強化しています。
アジア太平洋地域のがん光線力学療法市場において、単独療法は、その簡便性、費用対効果の高さ、そして併用療法に比べて副作用が少ないことから、年平均成長率7.2%で成長しており、最も急成長している分野です。追加の薬剤や介入を必要とせずに腫瘍を標的とした治療が可能であるため、患者のコンプライアンスが向上します。外来診療における導入の増加、低侵襲治療への意識の高まり、そして光感受性剤と光照射システムの進歩が、この分野の急速な成長をさらに牽引しています。
- 手順別テクニック
アジア太平洋地域のがん光線力学療法市場は、治療技術に基づいて、体外照射、体腔内（内視鏡的）照射、組織内（体内）照射、その他に分類されます。2025年には、体外照射セグメントが非侵襲性、使いやすさ、そして表在性腫瘍への有効性から、69.22%の市場シェアを獲得し、市場を席巻すると予想されています。先進的な医療インフラと保険償還政策に支えられた積極的な導入に加え、アジア太平洋地域におけるがん罹患率と認知度の高まりに伴う需要の高まりが、このセグメントの市場リーダーシップを牽引しています。
アジア太平洋がん光線力学療法市場において、腔内（内視鏡）送達セグメントは、低侵襲処置の採用増加、消化器がんおよび胸部がんの罹患率上昇、内視鏡機器の技術的進歩、全身的副作用を軽減する標的および局所的治療アプローチの好ましさの高まりにより、CAGR 8.8%で最も急速に成長しています。
- 病気のステージ別
アジア太平洋地域のがん光線力学療法市場は、病期に基づいて、早期がんと後期がんに分類されます。2025年には、局所的な腫瘍へのPDTの有効性、健常組織へのダメージの最小化、そして美容上のメリットにより、早期がんセグメントが81.65%の市場シェアを獲得し、市場を牽引すると予想されています。このセグメントは、患者の高い認知度、低侵襲治療への嗜好、そしてアジア太平洋地域における広範な導入といった恩恵を受けており、がん診断率の上昇と腫瘍学インフラの拡充も、このセグメントの市場リーダーシップを支えています。
アジア太平洋地域のがん光線力学療法市場において、早期がんは年平均成長率（CAGR）6.8%で最も急成長している分野です。これは、低侵襲治療の導入拡大、早期発見への意識の高まり、そしてPDTによる患者転帰の改善によるものです。早期がんは標的療法への反応が良く、より高い効果とより少ない副作用をもたらします。さらに、政府の支援策や光感受性剤および光照射システムの進歩も、この分野の市場浸透を加速させています。
- 患者の人口統計別
アジア太平洋地域のがん光線力学療法市場は、患者人口統計に基づき、高齢者、成人、小児の3つに分類されています。2025年には、高齢者のがん罹患率の高さ、皮膚がんおよび皮膚癌に対する感受性の高まり、そして低侵襲性で標的を絞った治療への嗜好により、高齢者セグメントが67.74%の市場シェアを占め、市場を席巻すると予想されています。北米およびアジア太平洋地域では、先進的な医療インフラと意識、そして高齢者人口の増加に支えられ、光線力学療法の導入が進んでいます。
アジア太平洋地域のがん光線力学療法市場において、高齢者セグメントは6.9%のCAGR（年平均成長率）で最速の成長を遂げています。これは、高齢者のがん罹患率が高いことが要因です。加齢に伴い免疫系が弱まり、様々ながんに対する感受性が高まるため、PDTのような効果的で低侵襲な治療への需要が高まっています。さらに、PDTは副作用が少なく回復が早いため、積極的な治療に耐えられない高齢患者にも適しており、この年齢層における市場の成長を牽引しています。
- エンドユーザー別
アジア太平洋地域のがん光線力学療法市場は、エンドユーザー別に、病院、皮膚科・皮膚がんクリニック、外来手術センター（ASCS）、学術研究機関、その他に分類されます。2025年には、包括的なインフラ、専門の腫瘍科の存在、そして統合PDT治療の提供能力を背景に、病院セグメントが41.80%の市場シェアを獲得し、市場を席巻すると予想されています。北米とアジア太平洋地域の公立・私立病院、特にティア1およびティア2の施設は、高度な医療システムと保険償還サポートにより、PDTの導入をリードしています。病院ネットワークの拡大と腫瘍学サービスの拡大により、世界的にがんPDTの主要エンドユーザーとしての病院の優位性がさらに強化されています。
アジア太平洋地域のがん光線力学療法市場において、病院は年平均成長率7.5%で最も急成長しているセグメントです。これは、高度ながん治療の導入、患者流入の増加、そして専門の腫瘍科の存在によるものです。病院は診断、治療、そして治療後のケアを含む包括的なPDTサービスを提供しているため、独立したクリニックよりも好まれています。さらに、意識の高まり、政府の取り組み、そして保険適用範囲の拡大も、病院におけるPDTの導入をさらに促進しています。
- 流通チャネル別
アジア太平洋地域のがん光線力学療法市場は、流通チャネルに基づいて、直接入札、第三者販売代理店、オンライン、その他に分類されます。2025年には、病院、政府の医療プログラム、大規模な腫瘍センターによる大量調達により、光感受性剤およびPDT機器のコスト効率と安定供給が確保されるため、直接入札セグメントが51.18%の市場シェアで市場を席巻すると予想されます。北米およびアジア太平洋地域では、構造化された病院調達システムと公衆衛生入札、そして機関からの需要の増加に支えられ、導入が堅調に推移しています。
アジア太平洋地域のがん光線力学療法市場において、直接入札セグメントは年平均成長率7.0%で最も急成長しているセグメントです。これは、政府や病院による高度なPDT機器の直接契約による調達の増加によるものです。このアプローチは、大規模ながん治療プログラムにおいて、費用対効果、調達の迅速化、そして安定した供給を確保します。さらに、公的医療費の増加、がん治療に対する政府の取り組み、そして集中購買への志向が、販売代理店やオンラインチャネルよりも直接入札の採用を促進しています。
アジア太平洋地域におけるがん光線力学療法市場の地域分析
- 中国は、膨大な患者数、がん罹患率の上昇、そして医療費の増加に支えられ、2025年にはアジア太平洋地域のがん光線力学療法市場において43.73%という最大の収益シェアを獲得し、市場を席巻すると予想されています。先進がん治療に対する政府の強力な支援、革新的な治療法の導入拡大、そして主要な国内PDT機器メーカーの存在などがその背景にあります。
- 日本は、がん罹患率の上昇、高度な医療インフラ、そして革新的な治療法に対する強力な政府支援に支えられ、予測期間中にアジア太平洋地域のがん光線力学療法市場において8.9%のCAGRで最速の成長を遂げると予想されています。患者と医師の意識の高まりと、低侵襲療法の導入が相まって、需要が高まっています。
- さらに、医療インフラが拡大し、患者と医師の意識も高まっています。
オーストラリア・アジア太平洋地域におけるがん光線力学療法市場の洞察
オーストラリア・アジア太平洋地域のがん光線力学療法市場は、先進的な医療インフラ、強力な腫瘍学研究エコシステム、そして専門がんセンターの存在を背景に、アジア太平洋地域のがん治療において重要な役割を果たしています。革新的で低侵襲な治療法の普及率の高さ、がん治療に対する政府の支援的な取り組み、そして皮膚がんの発生率の上昇が市場の成長を牽引しています。さらに、オーストラリアの研究機関、大学、そして世界的な製薬企業との連携により、PDTの開発と商業化が加速しており、オーストラリアはアジア太平洋市場における重要な貢献国としての地位を確立しています。
韓国・アジア太平洋地域におけるがん光線力学療法市場の洞察
韓国のアジア太平洋地域におけるがん光線力学療法市場は、確立された医療制度、先進的ながん治療技術の急速な導入、そしてがん治療強化に向けた政府の強力な取り組みに支えられ、着実に成長すると予測されています。胃がん、肝臓がん、肺がんなどの罹患率の増加と、PDTなどの低侵襲治療への認知度の高まりが、需要を押し上げています。有利な償還枠組み、研究開発への投資、そして病院、大学、そして世界的なバイオ医薬品企業との連携は、韓国における市場浸透と持続的な成長をさらに加速させています。
市場で活動する主要なマーケットリーダーは次のとおりです。
- ノバルティスファーマAG（スイス）
- ガルデルマSA（スイス）
- バウシュ・ヘルス・カンパニーズ（カナダ）
- Photocure ASA（ノルウェー）
- アドバンツ・ファーマ社（英国）
- サン・ファーマシューティカル・インダストリーズ（インド）
- Biofrontera AG（ドイツ）
- LUMIBIRD SA（フランス）
- LUZITIN SA（ポルトガル）
- ルメダ株式会社（スウェーデン）
- ImPact Biotech（イスラエル）
- biolitec Holding GmbH & Co KG（ドイツ）
- モジュライトコーポレーション（フィンランド）
- THERALASE TECHNOLOGIES INC.（カナダ）
アジア太平洋地域におけるがん光線力学療法市場の最新動向
- 2023年2月、ガルデルマ社とGerman Medical Engineering（GME）は、皮膚科および光線力学療法（PDT）市場における戦略的展開を象徴する提携を開始しました。前癌性および非黒色腫皮膚がんに対する優れた光感受性剤であるガルデルマ社のMetvixとGME社のMultiLiteデバイスを組み合わせることで、この提携はガルデルマの統合治療製品ラインナップを強化し、従来の赤色光PDT（C-PDT）と、より患者様への負担が少ない人工昼光PDT（ADL-PDT）の両方を提供する能力を拡大します。
- 2025年、マッケソンはCore Ventures（コミュニティ腫瘍学再活性化エンタープライズベンチャー）の買収を完了し、約24億9000万米ドルで約70％の支配権を取得し、フロリダがん専門医＆研究機関を通じてコミュニティベースの腫瘍学ケアを強化しました。
- 2025年、Biofrontera AGはAmeluzおよびRhodoLEDに関連するすべての米国資産をBiofrontera Inc.に譲渡し、10%の株式と米国でのAmeluzの売上の12～15%のロイヤルティを受け取りました。
SKU-
世界初のマーケットインテリジェンスクラウドに関するレポートにオンラインでアクセスする
- インタラクティブなデータ分析ダッシュボード
- 成長の可能性が高い機会のための企業分析ダッシュボード
- カスタマイズとクエリのためのリサーチアナリストアクセス
- インタラクティブなダッシュボードによる競合分析
- 最新ニュース、更新情報、トレンド分析
- 包括的な競合追跡のためのベンチマーク分析のパワーを活用
目次
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.8 DBMR MARKET POSITION GRID
2.9 MARKET END USER COVERAGE GRID
2.1 SECONDARY SOURCES
2.11 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PORTER’S FIVE FORCES
4.2 PESTEL ANALYSIS
4.3 PRODUCTION CONSUMPTION ANALYSIS
4.3.1 INTRODUCTION
4.3.2 PRODUCTION SIDE ANALYSIS
4.3.2.1 PHOTOSENSITIZER MANUFACTURING
4.3.2.2 DEVICE MANUFACTURING
4.3.2.3 RESEARCH AND INNOVATION
4.3.3 CONSUMPTION SIDE ANALYSIS
4.3.3.1 CLINICAL APPLICATION
4.3.3.2 TREATMENT VOLUMES AND TRENDS
4.3.3.3 DOSAGE AND PROTOCOLS
4.3.4 PRODUCTION–CONSUMPTION DYNAMICS
4.3.4.1 SUPPLY CONSTRAINTS
4.3.4.2 REGIONAL OVERVIEW
4.3.4.3 FUTURE OUTLOOK
4.3.5 CONCLUSION
4.4 COST ANALYSIS BREAKDOWN
4.4.1 INTRODUCTION
4.4.2 DIRECT MEDICAL COSTS
4.4.2.1 COST OF PHOTOSENSITIZERS
4.4.2.2 LIGHT DELIVERY SYSTEMS
4.4.2.3 HEALTHCARE FACILITY CHARGES
4.4.3 INDIRECT COSTS
4.4.3.1 PATIENT-RELATED EXPENSES
4.4.3.2 POST-TREATMENT MONITORING
4.4.4 COMPARATIVE COST-EFFECTIVENESS
4.4.5 REIMBURSEMENT AND INSURANCE IMPACT
4.4.6 REGIONAL COST VARIATIONS
4.4.7 FUTURE COST TRENDS AND REDUCTION STRATEGIES
4.4.7.1 TECHNOLOGICAL ADVANCEMENTS
4.4.7.2 HEALTHCARE EFFICIENCY INITIATIVES
4.4.8 CONCLUSION
4.5 TECHNOLOGICAL ADVANCEMENTS
4.5.1 INTRODUCTION
4.5.2 NEXT-GENERATION PHOTOSENSITIZERS
4.5.3 ADVANCEMENTS IN LIGHT DELIVERY SYSTEMS
4.5.4 NANOTECHNOLOGY-ENABLED DELIVERY
4.5.5 COMBINATION THERAPIES AND IMMUNOMODULATION
4.5.6 DIGITAL INTEGRATION AND TREATMENT PLANNING
4.5.7 RECENT TRENDS AND OUTLOOK
4.5.8 CONCLUSION
4.6 VALUE CHAIN ANALYSIS
4.6.1 INTRODUCTION
4.6.2 RESEARCH & DEVELOPMENT
4.6.2.1 DISCOVERY OF PHOTOSENSITIZERS
4.6.2.2 DEVELOPMENT OF LIGHT DELIVERY SYSTEMS
4.6.2.3 CLINICAL TRIALS AND REGULATORY APPROVALS
4.6.3 MANUFACTURING
4.6.3.1 PRODUCTION OF PHOTOSENSITIZERS
4.6.3.2 FABRICATION OF LIGHT DELIVERY DEVICES
4.6.4 DISTRIBUTION & LOGISTICS
4.6.4.1 SUPPLY CHAIN MANAGEMENT
4.6.4.2 INTERNATIONAL TRADE AND MARKET ACCESS
4.6.5 CLINICAL APPLICATION
4.6.5.1 INTEGRATION INTO TREATMENT PROTOCOLS
4.6.5.2 TRAINING AND EDUCATION
4.6.6 POST-TREATMENT MONITORING & SUPPORT
4.6.6.1 FOLLOW-UP CARE
4.6.6.2 PATIENT SUPPORT SERVICES
4.6.7 TECHNOLOGICAL ADVANCEMENTS INFLUENCING THE PDT VALUE CHAIN
4.6.7.1 NANOTECHNOLOGY IN PDT
4.6.7.2 ARTIFICIAL INTELLIGENCE AND IMAGING
4.6.7.3 PERSONALIZED MEDICINE
4.6.8 CONCLUSION
4.7 VENDOR SELECTION CRITERIA
4.7.1 INTRODUCTION
4.7.2 CORE SELECTION CRITERIA
4.7.2.1 REGULATORY COMPLIANCE
4.7.2.2 CLINICAL EVIDENCE AND RESEARCH SUPPORT
4.7.2.3 TECHNICAL PERFORMANCE AND DEVICE COMPATIBILITY
4.7.2.4 QUALITY MANAGEMENT AND MANUFACTURING STANDARDS
4.7.2.5 SERVICE, TRAINING, AND AFTER-SALES SUPPORT
4.7.2.6 SUPPLY CHAIN RELIABILITY
4.7.3 RECENT TRENDS IN VENDOR SELECTION
4.7.4 RISK FACTORS AND VULNERABILITIES
4.7.5 KEY PERFORMANCE INDICATORS
4.7.6 STRATEGIC RECOMMENDATIONS
4.7.7 CONCLUSION
4.8 PATENT ANALYSIS
4.8.1 PATENT QUALITY AND STRENGTH
4.8.2 PATENT FAMILIES
4.8.3 LICENSING AND COLLABORATIONS
4.8.4 REGIONAL PATENT LANDSCAPE
4.8.5 IP STRATEGY AND MANAGEMENT
4.9 SUPPLY CHAIN ANALYSIS
4.9.1 OVERVIEW
4.9.2 LOGISTIC COST SCENARIO
4.9.3 IMPORTANCE OF LOGISTICS SERVICE PROVIDERS
4.9.4 CONCLUSION
4.1 INDUSTRY ECOSYSTEM ANALYSIS
4.10.1 INTRODUCTION
4.10.2 ECOSYSTEM ARCHITECTURE — KEY ACTORS AND ROLES
4.10.2.1 CORE TECHNOLOGY PROVIDERS
4.10.2.2 ENABLING INSTITUTIONS
4.10.3 VALUE CHAIN AND FUNCTIONAL FLOWS
4.10.3.1 RESEARCH AND DISCOVERY
4.10.3.2 CLINICAL DEVELOPMENT AND REGULATORY VALIDATION
4.10.3.3 MANUFACTURING AND QUALITY ASSURANCE
4.10.3.4 DISTRIBUTION, PROCUREMENT AND CLINICAL ADOPTION
4.10.4 MARKET ENABLERS AND INFRASTRUCTURE
4.10.4.1 SCIENTIFIC AND REGULATORY ENABLERS
4.10.4.2 REIMBURSEMENT AND HEALTH-ECONOMICS INFRASTRUCTURE
4.10.4.3 MANUFACTURING AND SUPPLY-CHAIN CAPACITY
4.10.5 INTERDEPENDENCIES AND STRATEGIC PARTNERSHIPS
4.10.5.1 ACADEMIA-INDUSTRY TECHNOLOGY TRANSFER
4.10.5.2 VERTICAL INTEGRATION AND CONTRACT MANUFACTURING
4.10.5.3 CLINICAL NETWORKS AND KOL ECOSYSTEMS
4.10.6 RISKS, CONSTRAINTS AND SYSTEMIC VULNERABILITIES
4.10.6.1 REGULATORY COMPLEXITY FOR COMBINED PRODUCTS
4.10.6.2 SUPPLY-CHAIN CONCENTRATION AND MATERIAL RISK
4.10.6.3 EVIDENCE AND REIMBURSEMENT UNCERTAINTY
4.10.6.4 CLINICAL OPERATIONAL BARRIERS
4.10.7 STRATEGIC IMPLICATIONS AND RECOMMENDATIONS
4.10.8 OUTLOOK — EVOLUTION OF THE ECOSYSTEM
4.10.9 CONCLUSION
4.11 INNOVATION TRACKER AND STRATEGIC ANALYSIS
4.11.1 INTRODUCTION
4.11.2 RECENT TECHNOLOGICAL INNOVATIONS
4.11.2.1 ADVANCED PHOTOSENSITIZERS
4.11.2.2 OXYGEN-SELF-SUFFICIENT PLATFORMS
4.11.2.3 ALTERNATIVE ACTIVATION MODALITIES
4.11.2.4 SMART NANOPLATFORMS
4.11.2.5 NOVEL CHEMICAL STRUCTURES
4.11.3 STRATEGIC INNOVATIONS IN DELIVERY SYSTEMS
4.11.3.1 LIGHT DELIVERY DEVICES
4.11.3.2 COMBINATION THERAPIES
4.11.3.3 IMAGING INTEGRATION
4.11.4 KEY CHALLENGES
4.11.5 STRATEGIC THEMES
4.11.6 STRATEGIC IMPLICATIONS FOR MARKET PLAYERS
4.11.7 RECOMMENDATIONS
4.11.8 OUTLOOK AND STRATEGIC RISKS
4.11.9 CONCLUSION
4.12 PRICING ANALYSIS
4.12.1 INTRODUCTION
4.12.2 COMPONENTS OF THE TOTAL TREATMENT PRICE
4.12.2.1 PHOTOSENSITIZING AGENT (DRUG) COSTS
4.12.2.2 DEVICE CAPITAL AND MAINTENANCE COST
4.12.2.3 CONSUMABLES AND PROCEDURAL OVERHEAD
4.12.2.4 INDIRECT AND DOWNSTREAM COSTS
4.12.3 PRICING MODELS AND APPROACHES
4.12.3.1 COST-PLUS AND MARKUP MODELS
4.12.3.2 VALUE-BASED AND OUTCOMES-LINKED PRICING
4.12.3.3 BUNDLED PAYMENTS AND PROCEDURAL TARIFFS
4.12.3.4 SUBSCRIPTION AND MANAGED-SERVICE MODELS FOR DEVICES
4.12.4 REIMBURSEMENT LANDSCAPE
4.12.4.1 UNITED STATES: MEDICARE AND COMMERCIAL PAYERS
4.12.4.2 EUROPE AND OTHER HIGH-INCOME MARKETS
4.12.4.3 EMERGING MARKETS AND OUT-OF-POCKET DYNAMICS
4.12.5 REGIONAL PRICE DIFFERENTIALS AND DRIVERS
4.12.5.1 MANUFACTURING FOOTPRINT AND SUPPLY-CHAIN EFFECTS
4.12.5.2 REGULATORY BURDEN AND MARKET ACCESS TIMELINES
4.12.5.3 CLINICAL PRACTICE PATTERNS AND REIMBURSEMENT POLICY
4.12.6 PRICE SENSITIVITY, ACCESS, AND EQUITY
4.12.6.1 PRICE ELASTICITY IN HOSPITAL PROCUREMENT
4.12.6.2 PATIENT ACCESS AND SOCIOECONOMIC BARRIERS
4.12.7 COMPETITIVE & STRATEGIC PRICING IMPLICATIONS
4.12.7.1 DIFFERENTIATION-BASED PREMIUM PRICING
4.12.7.2 PENETRATION PRICING AND VOLUME STRATEGIES
4.12.7.3 MANAGED ENTRY AGREEMENTS AND OUTCOMES GUARANTEES
4.12.8 RECOMMENDATIONS FOR STAKEHOLDERS
4.12.8.1 FOR MANUFACTURERS
4.12.8.2 FOR PROVIDERS AND HOSPITAL SYSTEMS
4.12.8.3 FOR PAYERS AND POLICYMAKERS
4.12.9 RISKS, UNCERTAINTIES, AND FUTURE PRICE PRESSURES
4.12.10 CONCLUSION
5 TARIFFS & IMPACT ON THE MARKET
5.1 INTRODUCTION
5.2 TARIFF LANDSCAPE RELEVANT TO PDT PRODUCTS
5.2.1 CATEGORIES OF TRADE EXPOSURE
5.2.2 RECENT AND EMERGING TARIFF MEASURES OF CONSEQUENCE
5.3 DIRECT COST IMPACTS
5.3.1 INCREASED LANDED COSTS AND MARGIN COMPRESSION
5.3.2 PRICE VOLATILITY AND PROCUREMENT BUDGETING
5.4 SUPPLY-CHAIN & MANUFACTURING IMPLICATIONS
5.4.1 SUPPLIER DIVERSIFICATION AND RESHORING INCENTIVES
5.4.2 SOURCING OF HIGH-VALUE NANOMATERIALS AND COMPONENTS
5.4.3 REGULATORY AND QUALIFICATION COSTS FOR NEW SUPPLIERS
5.5 CLINICAL ACCESS, PRICING & REIMBURSEMENT EFFECTS
5.5.1 ACCESS RISK FOR PATIENTS AND PROVIDERS
5.5.2 REIMBURSEMENT PRESSURE AND HEALTH-ECONOMIC ASSESSMENTS
5.6 R&D, INNOVATION & COMPETITIVE IMPLICATIONS
5.6.1 DISRUPTION OF RESEARCH SUPPLIES AND COLLABORATION FLOWS
5.6.2 STRATEGIC REPOSITIONING AND COMPETITIVE ADVANTAGE
5.7 POLICY, COMPLIANCE & REGULATORY CONSIDERATIONS
5.7.1 USE OF WTO AND PREFERENTIAL TRADE RULES
5.7.2 TARIFF MITIGATION TOOLS AND ADVOCACY
5.8 RECOMMENDATIONS FOR STAKEHOLDERS
5.9 CONCLUSION
6 REGULATION COVERAGE
6.1 PRODUCT CODES
6.1.1 CERTIFIED STANDARDS
6.1.2 SAFETY STANDARDS
6.1.3 MATERIAL HANDLING & STORAGE
6.1.4 TRANSPORT & PRECAUTIONS
6.1.5 HAZARD IDENTIFICATION
6.1.6 CONCLUSION
7 MARKET OVERVIEW
7.1 DRIVERS
7.1.1 INCREASING PREVALENCE OF CANCER
7.1.2 GROWING PREFERENCE FOR MINIMALLY INVASIVE THERAPIES
7.1.3 TECHNOLOGICAL ADVANCEMENTS IN PHOTOSENSITIZERS AND DEVICES
7.1.4 EXPANDING RESEARCH AND CLINICAL DEVELOPMENT PIPELINE
7.2 RESTRAINTS
7.2.1 LIMITED DEPTH OF LIGHT PENETRATION
7.2.2 HIGH COST OF TREATMENT
7.3 OPPORTUNITIES
7.3.1 INTEGRATION WITH OTHER CANCER THERAPIES
7.3.2 DEVELOPMENT OF NOVEL PHOTOSENSITIZERS
7.3.3 M&A AND PARTNERSHIPS WITH ONCOLOGY DEVICE/LASER FIRMS AND PHARMA
7.4 CHALLENGES
7.4.1 TUMOR HYPOXIA AS A BIOLOGICAL BARRIER TO PHOTODYNAMIC THERAPY EFFICACY
7.4.2 COMPETITION FROM ALTERNATIVE TREATMENTS
8 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE
8.1 OVERVIEW
8.2 PHOTOSENSITIZER DRUGS
8.3 PHOTODYNAMIC THERAPY DEVICES
9 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET, BY CANCER INDICATION
9.1 OVERVIEW
9.2 SKIN & CUTANEOUS ONCOLOGY
9.3 HEAD & NECK
9.4 ESOPHAGAL
9.5 LUNG
9.6 BLADDER
9.7 CERVICAL
9.8 PROSTATE
10 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET, BY THERAPY MODALITY
10.1 OVERVIEW
10.2 STANDALONE THERAPY
10.3 ADJUNCTIVE THERAPY
10.4 PALLIATION THERAPY
10.5 OTHERS
11 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET, BY PROCEDURE TECHNIQUE
11.1 OVERVIEW
11.2 EXTERNAL BEAM
11.3 INTRACAVITARY (ENDOSCOPIC) DELIVERY
11.4 INTERSTITIAL (INTERNAL) DELIVERY
11.5 OTHERS
12 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET, BY DISEASE STAGE
12.1 OVERVIEW
12.2 EARLY-STAGE CANCER
12.3 LATE-STAGE CANCER
13 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS
13.1 OVERVIEW
13.2 GERIATRIC
13.3 ADULTS
13.4 PEDIATRIC
14 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET, BY END USER
14.1 OVERVIEW
14.2 HOSPITALS
14.3 DERMATOLOGY & SKIN-CANCER CLINICS
14.4 AMBULATORY SURGICAL CENTERS (ASCS)
14.5 ACADEMIC & RESEARCH INSTITUTES
14.6 OTHERS
15 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET, BY DISTRIBUTION CHANNEL
15.1 OVERVIEW
15.2 DIRECT TENDER
15.3 THIRD PARTY DISTRIBUTORS
15.4 ONLINE
15.5 OTHERS
16 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET, BY REGION
16.1 ASIA-PACIFIC
16.1.1 CHINA
16.1.2 JAPAN
16.1.3 SOUTH KOREA
16.1.4 AUSTRAILA
16.1.5 TAIWAN
16.1.6 INDIA
16.1.7 INDONESIA
16.1.8 HONG KONG
16.1.9 NEW ZEALAND
16.1.10 SINGAPORE
16.1.11 PHILIPPINES
16.1.12 THAILAND
16.1.13 MALAYSIA
16.1.14 REST OF ASIA-PACIFIC
17 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET : COMPANY LANDSCAPE
17.1 COMPANY SHARE ANALYSIS: GLOBAL
18 SWOT ANALYSIS
19 COMPANY PROFILE
19.1 NOVERTIS AG
19.1.1 COMPANY SNAPSHOT
19.1.2 REVENUE ANALYSIS
19.1.3 COMPANY SHARE ANALYSIS
19.1.4 PRODUCT PORTFOLIO
19.1.5 RECENT DEVELOPMENT
19.2 GALDERMA S. A.
19.2.1 COMPANY SNAPSHOT
19.2.2 REVENUE ANALYSIS
19.2.3 COMPANY SHARE ANALYSIS
19.2.4 PRODUCT PORTFOLIO
19.2.5 RECENT DEVELOPMENTS
19.3 PHOTOCURE
19.3.1 COMPANY SNAPSHOT
19.3.2 REVENUE ANALYSIS
19.3.3 COMPANY SHARE ANALYSIS
19.3.4 PRODUCT PORTFOLIO
19.3.5 RECENT DEVELOPMENT
19.4 ADVANZ PHARMA CORP.
19.4.1 COMPANY SNAPSHOT
19.4.2 COMPANY SHARE ANALYSIS
19.4.3 PRODUCT PORTFOLIO
19.4.4 RECENT DEVELOPMENT
19.5 AMERISOURCE BERGEN CORPORATION
19.5.1 COMPANY SNAPSHOT
19.5.2 REVENUE ANALYSIS
19.5.3 COMPANY SHARE ANALYSIS
19.5.4 PRODUCT PORTFOLIO
19.5.5 RECENT DEVELOPMENT
19.6 BIOFRONTERA AG
19.6.1 COMPANY SNAPSHOT
19.6.2 REVENUE ANALYSIS
19.6.3 PRODUCT PORTFOLIO
19.6.4 RECENT DEVELOPMENTS
19.7 BIOLITEC HOLDING GMBH & CO KG
19.7.1 COMPANY SNAPSHOT
19.7.2 PRODUCT PORTFOLIO
19.7.3 RECENT DEVELOPMENT
19.8 CARDINAL HEALTH
19.8.1 COMPANY SNAPSHOT
19.8.2 REVENUE ANALYSIS
19.8.3 PRODUCT PORTFOLIO
19.8.4 RECENT DEVELOPMENT
19.9 HEMERION THERAPEUTICS
19.9.1 COMPANY SNAPSHOT
19.9.2 PRODUCT PORTFOLIO
19.9.3 RECENT DEVELOPMENTS
19.1 IMPACT BIOTECH
19.10.1 COMPANY SNAPSHOT
19.10.2 PRODUCT PORTFOLIO
19.10.3 RECENT DEVELOPMENTS
19.11 INOVA
19.11.1 COMPANY SNAPSHOT
19.11.2 PRODUCT PORTFOLIO
19.11.3 RECENT DEVELOPMENT
19.12 LUMIBIRD
19.12.1 COMPANY SNAPSHOT
19.12.2 REVENUE ANALYSIS
19.12.3 PRODUCT PORTFOLIO
19.12.4 RECENT DEVELOPMENT
19.13 LUZITIN
19.13.1 COMPANY SNAPSHOT
19.13.2 PRODUCT PORTFOLIO
19.13.3 RECENT DEVELOPMENT
19.14 MCKESSON
19.14.1 COMPANY SNAPSHOT
19.14.2 REVENUE ANALYSIS
19.14.3 PRODUCT PORTFOLIO
19.14.4 RECENT DEVELOPMENTS
19.15 MODULIGHT CORPORATION
19.15.1 COMPANY SNAPSHOT
19.15.2 REVENUE ANALYSIS
19.15.3 PRODUCT PORTFOLIO
19.15.4 RECENT DEVELOPMENT
19.16 ONCOLUX INC (FORMERLY LUMEDA INC.)
19.16.1 COMPANY SNAPSHOT
19.16.2 PRODUCT PORTFOLIO
19.16.3 RECENT DEVELOPMENT
19.17 SUN PHARMACEUTICAL INDUSTRIES LTD
19.17.1 COMPANY SNAPSHOT
19.17.2 REVENUE ANALYSIS
19.17.3 PRODUCT PORTFOLIO
19.17.4 RECENT DEVELOPMENT
19.18 THERALASE TECHNOLOGIES INC.
19.18.1 COMPANY SNAPSHOT
19.18.2 REVENUSE ANALYSIS
19.18.3 PRODUCT PORTFOLIO
19.18.4 RECENT DEVELOPMENT
20 QUESTIONNAIRE
21 RELATED REPORTS
表のリスト
TABLE 1 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 2 ASIA-PACIFIC PHOTOSENSITIZER DRUGS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY REGION, 2019-2028 (USD THOUSAND)
TABLE 3 ASIA-PACIFIC PHOTOSENSITIZER DRUGS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY CLASS, 2018-2032 (USD THOUSAND)
TABLE 4 ASIA-PACIFIC PHOTOSENSITIZER DRUGS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY FORMULATION, 2018-2032 (USD THOUSAND)
TABLE 5 ASIA-PACIFIC PHOTODYNAMIC THERAPY DEVICES IN CANCER PHOTODYNAMIC THERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 6 ASIA-PACIFIC PHOTODYNAMIC THERAPY DEVICES IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 7 ASIA-PACIFIC LIGHT DELIVERY SYSTEMS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 8 ASIA-PACIFIC ACCESSORIES & CONSUMABLES IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 9 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET, BY CANCER INDICATION, 2018-2032 (USD THOUSAND)
TABLE 10 ASIA-PACIFIC SKIN & CUTANEOUS ONCOLOGY IN CANCER PHOTODYNAMIC THERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 11 ASIA-PACIFIC SKIN & CUTANEOUS ONCOLOGY IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 12 ASIA-PACIFIC SKIN & CUTANEOUS ONCOLOGY IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 13 ASIA-PACIFIC HEAD & NECK IN CANCER PHOTODYNAMIC THERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 14 ASIA-PACIFIC HEAD & NECK IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 15 ASIA-PACIFIC HEAD & NECK IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 16 ASIA-PACIFIC ESOPHAGAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 17 ASIA-PACIFIC ESOPHAGAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 18 ASIA-PACIFIC ESOPHAGAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 19 ASIA-PACIFIC LUNG IN CANCER PHOTODYNAMIC THERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 20 ASIA-PACIFIC LUNG IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 21 ASIA-PACIFIC LUNG IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 22 ASIA-PACIFIC BLADDER IN CANCER PHOTODYNAMIC THERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 23 ASIA-PACIFIC BLADDER IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 24 ASIA-PACIFIC BLADDER IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 25 ASIA-PACIFIC CERVICAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 26 ASIA-PACIFIC CERVICAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 27 ASIA-PACIFIC CERVICAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 28 ASIA-PACIFIC PROSTATE IN CANCER PHOTODYNAMIC THERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 29 ASIA-PACIFIC PROSTATE IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 30 ASIA-PACIFIC PROSTATE IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 31 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET, BY THERAPY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 32 ASIA-PACIFIC STANDALONE THERAPY IN CANCER PHOTODYNAMIC THERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 33 ASIA-PACIFIC ADJUNCTIVE THERAPY IN CANCER PHOTODYNAMIC THERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 34 ASIA-PACIFIC PALLIATION THERAPY IN CANCER PHOTODYNAMIC THERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 35 ASIA-PACIFIC OTHERS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 36 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET, BY PROCEDURE TECHNIQUE, 2018-2032 (USD THOUSAND)
TABLE 37 ASIA-PACIFIC EXTERNAL BEAM IN CANCER PHOTODYNAMIC THERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 38 ASIA-PACIFIC INTRACAVITARY (ENDOSCOPIC) DELIVERY IN CANCER PHOTODYNAMIC THERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 39 ASIA-PACIFIC INTERSTITIAL (INTERNAL) DELIVERY IN CANCER PHOTODYNAMIC THERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 40 ASIA-PACIFIC OTHERS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 41 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET, BY DISEASE STAGE, 2018-2032 (USD THOUSAND)
TABLE 42 ASIA-PACIFIC EARLY-STAGE CANCER IN CANCER PHOTODYNAMIC THERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 43 ASIA-PACIFIC LATE-STAGE CANCER IN CANCER PHOTODYNAMIC THERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 44 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 45 ASIA-PACIFIC GERIATRIC IN CANCER PHOTODYNAMIC THERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 46 ASIA-PACIFIC ADULTS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 47 ASIA-PACIFIC PEDIATRIC IN CANCER PHOTODYNAMIC THERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 48 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 49 ASIA-PACIFIC HOSPITALS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 50 ASIA-PACIFIC HOSPITALS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 51 ASIA-PACIFIC HOSPITALS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY SIZE, 2018-2032 (USD THOUSAND)
TABLE 52 ASIA-PACIFIC DERMATOLOGY & SKIN-CANCER CLINICS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 53 ASIA-PACIFIC AMBULATORY SURGICAL CENTERS (ASCS) IN CANCER PHOTODYNAMIC THERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 54 ASIA-PACIFIC ACADEMIC & RESEARCH INSTITUTES IN CANCER PHOTODYNAMIC THERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 55 ASIA-PACIFIC OTHERS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 56 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 57 ASIA-PACIFIC DIRECT TENDER IN CANCER PHOTODYNAMIC THERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 58 ASIA-PACIFIC THIRD PARTY DISTRIBUTORS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 59 ASIA-PACIFIC ONLINE IN CANCER PHOTODYNAMIC THERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 60 ASIA-PACIFIC OTHERS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 61 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET, BY COUNTRY, 2018-2032 (USD THOUSAND)
TABLE 62 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 63 ASIA-PACIFIC PHOTOSENSITIZER DRUGS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY CLASS, 2018-2032 (USD THOUSAND)
TABLE 64 ASIA-PACIFIC PHOTOSENSITIZER DRUGS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY FORMULATION, 2018-2032 (USD THOUSAND)
TABLE 65 ASIA-PACIFIC PHOTODYNAMIC THERAPY DEVICES IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 66 ASIA-PACIFIC LIGHT DELIVERY SYSTEMS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 67 ASIA-PACIFIC ACCESSORIES & CONSUMABLES IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 68 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET, BY CANCER INDICATION, 2018-2032 (USD THOUSAND)
TABLE 69 ASIA-PACIFIC SKIN & CUTANEOUS ONCOLOGY IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 70 ASIA-PACIFIC SKIN & CUTANEOUS ONCOLOGY IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 71 ASIA-PACIFIC HEAD & NECK IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 72 ASIA-PACIFIC HEAD & NECK IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 73 ASIA-PACIFIC ESOPHAGAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 74 ASIA-PACIFIC ESOPHAGAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 75 ASIA-PACIFIC LUNG IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 76 ASIA-PACIFIC LUNG IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 77 ASIA-PACIFIC BLADDER IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 78 ASIA-PACIFIC BLADDER IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 79 ASIA-PACIFIC CERVICAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 80 ASIA-PACIFIC CERVICAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 81 ASIA-PACIFIC PROSTATE IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 82 ASIA-PACIFIC PROSTATE IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 83 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET, BY THERAPY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 84 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET, BY PROCEDURE TECHNIQUE, 2018-2032 (USD THOUSAND)
TABLE 85 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET, BY DISEASE STAGE, 2018-2032 (USD THOUSAND)
TABLE 86 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 87 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 88 ASIA-PACIFIC HOSPITALS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 89 ASIA-PACIFIC HOSPITALS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY SIZE, 2018-2032 (USD THOUSAND)
TABLE 90 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 91 CHINA CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 92 CHINA PHOTOSENSITIZER DRUGS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY CLASS, 2018-2032 (USD THOUSAND)
TABLE 93 CHINA PHOTOSENSITIZER DRUGS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY FORMULATION, 2018-2032 (USD THOUSAND)
TABLE 94 CHINA PHOTODYNAMIC THERAPY DEVICES IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 95 CHINA LIGHT DELIVERY SYSTEMS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 96 CHINA ACCESSORIES & CONSUMABLES IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 97 CHINA CANCER PHOTODYNAMIC THERAPY MARKET, BY CANCER INDICATION, 2018-2032 (USD THOUSAND)
TABLE 98 CHINA SKIN & CUTANEOUS ONCOLOGY IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 99 CHINA SKIN & CUTANEOUS ONCOLOGY IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 100 CHINA HEAD & NECK IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 101 CHINA HEAD & NECK IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 102 CHINA ESOPHAGAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 103 CHINA ESOPHAGAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 104 CHINA LUNG IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 105 CHINA LUNG IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 106 CHINA BLADDER IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 107 CHINA BLADDER IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 108 CHINA CERVICAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 109 CHINA CERVICAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 110 CHINA PROSTATE IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 111 CHINA PROSTATE IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 112 CHINA CANCER PHOTODYNAMIC THERAPY MARKET, BY THERAPY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 113 CHINA CANCER PHOTODYNAMIC THERAPY MARKET, BY PROCEDURE TECHNIQUE, 2018-2032 (USD THOUSAND)
TABLE 114 CHINA CANCER PHOTODYNAMIC THERAPY MARKET, BY DISEASE STAGE, 2018-2032 (USD THOUSAND)
TABLE 115 CHINA CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 116 CHINA CANCER PHOTODYNAMIC THERAPY MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 117 CHINA HOSPITALS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 118 CHINA HOSPITALS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY SIZE, 2018-2032 (USD THOUSAND)
TABLE 119 CHINA CANCER PHOTODYNAMIC THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 120 JAPAN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 121 JAPAN PHOTOSENSITIZER DRUGS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY CLASS, 2018-2032 (USD THOUSAND)
TABLE 122 JAPAN PHOTOSENSITIZER DRUGS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY FORMULATION, 2018-2032 (USD THOUSAND)
TABLE 123 JAPAN PHOTODYNAMIC THERAPY DEVICES IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 124 JAPAN LIGHT DELIVERY SYSTEMS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 125 JAPAN ACCESSORIES & CONSUMABLES IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 126 JAPAN CANCER PHOTODYNAMIC THERAPY MARKET, BY CANCER INDICATION, 2018-2032 (USD THOUSAND)
TABLE 127 JAPAN SKIN & CUTANEOUS ONCOLOGY IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 128 JAPAN SKIN & CUTANEOUS ONCOLOGY IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 129 JAPAN HEAD & NECK IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 130 JAPAN HEAD & NECK IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 131 JAPAN ESOPHAGAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 132 JAPAN ESOPHAGAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 133 JAPAN LUNG IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 134 JAPAN LUNG IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 135 JAPAN BLADDER IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 136 JAPAN BLADDER IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 137 JAPAN CERVICAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 138 JAPAN CERVICAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 139 JAPAN PROSTATE IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 140 JAPAN PROSTATE IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 141 JAPAN CANCER PHOTODYNAMIC THERAPY MARKET, BY THERAPY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 142 JAPAN CANCER PHOTODYNAMIC THERAPY MARKET, BY PROCEDURE TECHNIQUE, 2018-2032 (USD THOUSAND)
TABLE 143 JAPAN CANCER PHOTODYNAMIC THERAPY MARKET, BY DISEASE STAGE, 2018-2032 (USD THOUSAND)
TABLE 144 JAPAN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 145 JAPAN CANCER PHOTODYNAMIC THERAPY MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 146 JAPAN HOSPITALS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 147 JAPAN HOSPITALS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY SIZE, 2018-2032 (USD THOUSAND)
TABLE 148 JAPAN CANCER PHOTODYNAMIC THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 149 SOUTH KOREA CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 150 SOUTH KOREA PHOTOSENSITIZER DRUGS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY CLASS, 2018-2032 (USD THOUSAND)
TABLE 151 SOUTH KOREA PHOTOSENSITIZER DRUGS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY FORMULATION, 2018-2032 (USD THOUSAND)
TABLE 152 SOUTH KOREA PHOTODYNAMIC THERAPY DEVICES IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 153 SOUTH KOREA LIGHT DELIVERY SYSTEMS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 154 SOUTH KOREA ACCESSORIES & CONSUMABLES IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 155 SOUTH KOREA CANCER PHOTODYNAMIC THERAPY MARKET, BY CANCER INDICATION, 2018-2032 (USD THOUSAND)
TABLE 156 SOUTH KOREA SKIN & CUTANEOUS ONCOLOGY IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 157 SOUTH KOREA SKIN & CUTANEOUS ONCOLOGY IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 158 SOUTH KOREA HEAD & NECK IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 159 SOUTH KOREA HEAD & NECK IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 160 SOUTH KOREA ESOPHAGAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 161 SOUTH KOREA ESOPHAGAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 162 SOUTH KOREA LUNG IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 163 SOUTH KOREA LUNG IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 164 SOUTH KOREA BLADDER IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 165 SOUTH KOREA BLADDER IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 166 SOUTH KOREA CERVICAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 167 SOUTH KOREA CERVICAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 168 SOUTH KOREA PROSTATE IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 169 SOUTH KOREA PROSTATE IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 170 SOUTH KOREA CANCER PHOTODYNAMIC THERAPY MARKET, BY THERAPY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 171 SOUTH KOREA CANCER PHOTODYNAMIC THERAPY MARKET, BY PROCEDURE TECHNIQUE, 2018-2032 (USD THOUSAND)
TABLE 172 SOUTH KOREA CANCER PHOTODYNAMIC THERAPY MARKET, BY DISEASE STAGE, 2018-2032 (USD THOUSAND)
TABLE 173 SOUTH KOREA CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 174 SOUTH KOREA CANCER PHOTODYNAMIC THERAPY MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 175 SOUTH KOREA HOSPITALS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 176 SOUTH KOREA HOSPITALS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY SIZE, 2018-2032 (USD THOUSAND)
TABLE 177 SOUTH KOREA CANCER PHOTODYNAMIC THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 178 AUSTRALIA CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 179 AUSTRALIA PHOTOSENSITIZER DRUGS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY CLASS, 2018-2032 (USD THOUSAND)
TABLE 180 AUSTRALIA PHOTOSENSITIZER DRUGS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY FORMULATION, 2018-2032 (USD THOUSAND)
TABLE 181 AUSTRALIA PHOTODYNAMIC THERAPY DEVICES IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 182 AUSTRALIA LIGHT DELIVERY SYSTEMS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 183 AUSTRALIA ACCESSORIES & CONSUMABLES IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 184 AUSTRALIA CANCER PHOTODYNAMIC THERAPY MARKET, BY CANCER INDICATION, 2018-2032 (USD THOUSAND)
TABLE 185 AUSTRALIA SKIN & CUTANEOUS ONCOLOGY IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 186 AUSTRALIA SKIN & CUTANEOUS ONCOLOGY IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 187 AUSTRALIA HEAD & NECK IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 188 AUSTRALIA HEAD & NECK IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 189 AUSTRALIA ESOPHAGAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 190 AUSTRALIA ESOPHAGAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 191 AUSTRALIA LUNG IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 192 AUSTRALIA LUNG IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 193 AUSTRALIA BLADDER IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 194 AUSTRALIA BLADDER IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 195 AUSTRALIA CERVICAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 196 AUSTRALIA CERVICAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 197 AUSTRALIA PROSTATE IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 198 AUSTRALIA PROSTATE IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 199 AUSTRALIA CANCER PHOTODYNAMIC THERAPY MARKET, BY THERAPY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 200 AUSTRALIA CANCER PHOTODYNAMIC THERAPY MARKET, BY PROCEDURE TECHNIQUE, 2018-2032 (USD THOUSAND)
TABLE 201 AUSTRALIA CANCER PHOTODYNAMIC THERAPY MARKET, BY DISEASE STAGE, 2018-2032 (USD THOUSAND)
TABLE 202 AUSTRALIA CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 203 AUSTRALIA CANCER PHOTODYNAMIC THERAPY MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 204 AUSTRALIA HOSPITALS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 205 AUSTRALIA HOSPITALS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY SIZE, 2018-2032 (USD THOUSAND)
TABLE 206 AUSTRALIA CANCER PHOTODYNAMIC THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 207 TAIWAN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 208 TAIWAN PHOTOSENSITIZER DRUGS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY CLASS, 2018-2032 (USD THOUSAND)
TABLE 209 TAIWAN PHOTOSENSITIZER DRUGS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY FORMULATION, 2018-2032 (USD THOUSAND)
TABLE 210 TAIWAN PHOTODYNAMIC THERAPY DEVICES IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 211 TAIWAN LIGHT DELIVERY SYSTEMS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 212 TAIWAN ACCESSORIES & CONSUMABLES IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 213 TAIWAN CANCER PHOTODYNAMIC THERAPY MARKET, BY CANCER INDICATION, 2018-2032 (USD THOUSAND)
TABLE 214 TAIWAN SKIN & CUTANEOUS ONCOLOGY IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 215 TAIWAN SKIN & CUTANEOUS ONCOLOGY IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 216 TAIWAN HEAD & NECK IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 217 TAIWAN HEAD & NECK IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 218 TAIWAN ESOPHAGAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 219 TAIWAN ESOPHAGAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 220 TAIWAN LUNG IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 221 TAIWAN LUNG IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 222 TAIWAN BLADDER IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 223 TAIWAN BLADDER IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 224 TAIWAN CERVICAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 225 TAIWAN CERVICAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 226 TAIWAN PROSTATE IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 227 TAIWAN PROSTATE IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 228 TAIWAN CANCER PHOTODYNAMIC THERAPY MARKET, BY THERAPY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 229 TAIWAN CANCER PHOTODYNAMIC THERAPY MARKET, BY PROCEDURE TECHNIQUE, 2018-2032 (USD THOUSAND)
TABLE 230 TAIWAN CANCER PHOTODYNAMIC THERAPY MARKET, BY DISEASE STAGE, 2018-2032 (USD THOUSAND)
TABLE 231 TAIWAN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 232 TAIWAN CANCER PHOTODYNAMIC THERAPY MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 233 TAIWAN HOSPITALS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 234 TAIWAN HOSPITALS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY SIZE, 2018-2032 (USD THOUSAND)
TABLE 235 TAIWAN CANCER PHOTODYNAMIC THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 236 INDIA CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 237 INDIA PHOTOSENSITIZER DRUGS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY CLASS, 2018-2032 (USD THOUSAND)
TABLE 238 INDIA PHOTOSENSITIZER DRUGS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY FORMULATION, 2018-2032 (USD THOUSAND)
TABLE 239 INDIA PHOTODYNAMIC THERAPY DEVICES IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 240 INDIA LIGHT DELIVERY SYSTEMS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 241 INDIA ACCESSORIES & CONSUMABLES IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 242 INDIA CANCER PHOTODYNAMIC THERAPY MARKET, BY CANCER INDICATION, 2018-2032 (USD THOUSAND)
TABLE 243 INDIA SKIN & CUTANEOUS ONCOLOGY IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 244 INDIA SKIN & CUTANEOUS ONCOLOGY IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 245 INDIA HEAD & NECK IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 246 INDIA HEAD & NECK IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 247 INDIA ESOPHAGAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 248 INDIA ESOPHAGAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 249 INDIA LUNG IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 250 INDIA LUNG IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 251 INDIA BLADDER IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 252 INDIA BLADDER IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 253 INDIA CERVICAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 254 INDIA CERVICAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 255 INDIA PROSTATE IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 256 INDIA PROSTATE IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 257 INDIA CANCER PHOTODYNAMIC THERAPY MARKET, BY THERAPY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 258 INDIA CANCER PHOTODYNAMIC THERAPY MARKET, BY PROCEDURE TECHNIQUE, 2018-2032 (USD THOUSAND)
TABLE 259 INDIA CANCER PHOTODYNAMIC THERAPY MARKET, BY DISEASE STAGE, 2018-2032 (USD THOUSAND)
TABLE 260 INDIA CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 261 INDIA CANCER PHOTODYNAMIC THERAPY MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 262 INDIA HOSPITALS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 263 INDIA HOSPITALS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY SIZE, 2018-2032 (USD THOUSAND)
TABLE 264 INDIA CANCER PHOTODYNAMIC THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 265 INDONESIA CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 266 INDONESIA PHOTOSENSITIZER DRUGS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY CLASS, 2018-2032 (USD THOUSAND)
TABLE 267 INDONESIA PHOTOSENSITIZER DRUGS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY FORMULATION, 2018-2032 (USD THOUSAND)
TABLE 268 INDONESIA PHOTODYNAMIC THERAPY DEVICES IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 269 INDONESIA LIGHT DELIVERY SYSTEMS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 270 INDONESIA ACCESSORIES & CONSUMABLES IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 271 INDONESIA CANCER PHOTODYNAMIC THERAPY MARKET, BY CANCER INDICATION, 2018-2032 (USD THOUSAND)
TABLE 272 INDONESIA SKIN & CUTANEOUS ONCOLOGY IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 273 INDONESIA SKIN & CUTANEOUS ONCOLOGY IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 274 INDONESIA HEAD & NECK IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 275 INDONESIA HEAD & NECK IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 276 INDONESIA ESOPHAGAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 277 INDONESIA ESOPHAGAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 278 INDONESIA LUNG IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 279 INDONESIA LUNG IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 280 INDONESIA BLADDER IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 281 INDONESIA BLADDER IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 282 INDONESIA CERVICAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 283 INDONESIA CERVICAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 284 INDONESIA PROSTATE IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 285 INDONESIA PROSTATE IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 286 INDONESIA CANCER PHOTODYNAMIC THERAPY MARKET, BY THERAPY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 287 INDONESIA CANCER PHOTODYNAMIC THERAPY MARKET, BY PROCEDURE TECHNIQUE, 2018-2032 (USD THOUSAND)
TABLE 288 INDONESIA CANCER PHOTODYNAMIC THERAPY MARKET, BY DISEASE STAGE, 2018-2032 (USD THOUSAND)
TABLE 289 INDONESIA CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 290 INDONESIA CANCER PHOTODYNAMIC THERAPY MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 291 INDONESIA HOSPITALS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 292 INDONESIA HOSPITALS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY SIZE, 2018-2032 (USD THOUSAND)
TABLE 293 INDONESIA CANCER PHOTODYNAMIC THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 294 HONG KONG CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 295 HONG KONG PHOTOSENSITIZER DRUGS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY CLASS, 2018-2032 (USD THOUSAND)
TABLE 296 HONG KONG PHOTOSENSITIZER DRUGS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY FORMULATION, 2018-2032 (USD THOUSAND)
TABLE 297 HONG KONG PHOTODYNAMIC THERAPY DEVICES IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 298 HONG KONG LIGHT DELIVERY SYSTEMS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 299 HONG KONG ACCESSORIES & CONSUMABLES IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 300 HONG KONG CANCER PHOTODYNAMIC THERAPY MARKET, BY CANCER INDICATION, 2018-2032 (USD THOUSAND)
TABLE 301 HONG KONG SKIN & CUTANEOUS ONCOLOGY IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 302 HONG KONG SKIN & CUTANEOUS ONCOLOGY IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 303 HONG KONG HEAD & NECK IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 304 HONG KONG HEAD & NECK IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 305 HONG KONG ESOPHAGAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 306 HONG KONG ESOPHAGAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 307 HONG KONG LUNG IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 308 HONG KONG LUNG IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 309 HONG KONG BLADDER IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 310 HONG KONG BLADDER IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 311 HONG KONG CERVICAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 312 HONG KONG CERVICAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 313 HONG KONG PROSTATE IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 314 HONG KONG PROSTATE IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 315 HONG KONG CANCER PHOTODYNAMIC THERAPY MARKET, BY THERAPY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 316 HONG KONG CANCER PHOTODYNAMIC THERAPY MARKET, BY PROCEDURE TECHNIQUE, 2018-2032 (USD THOUSAND)
TABLE 317 HONG KONG CANCER PHOTODYNAMIC THERAPY MARKET, BY DISEASE STAGE, 2018-2032 (USD THOUSAND)
TABLE 318 HONG KONG CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 319 HONG KONG CANCER PHOTODYNAMIC THERAPY MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 320 HONG KONG HOSPITALS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 321 HONG KONG HOSPITALS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY SIZE, 2018-2032 (USD THOUSAND)
TABLE 322 HONG KONG CANCER PHOTODYNAMIC THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 323 NEW ZEALAND CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 324 NEW ZEALAND PHOTOSENSITIZER DRUGS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY CLASS, 2018-2032 (USD THOUSAND)
TABLE 325 NEW ZEALAND PHOTOSENSITIZER DRUGS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY FORMULATION, 2018-2032 (USD THOUSAND)
TABLE 326 NEW ZEALAND PHOTODYNAMIC THERAPY DEVICES IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 327 NEW ZEALAND LIGHT DELIVERY SYSTEMS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 328 NEW ZEALAND ACCESSORIES & CONSUMABLES IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 329 NEW ZEALAND CANCER PHOTODYNAMIC THERAPY MARKET, BY CANCER INDICATION, 2018-2032 (USD THOUSAND)
TABLE 330 NEW ZEALAND SKIN & CUTANEOUS ONCOLOGY IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 331 NEW ZEALAND SKIN & CUTANEOUS ONCOLOGY IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 332 NEW ZEALAND HEAD & NECK IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 333 NEW ZEALAND HEAD & NECK IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 334 NEW ZEALAND ESOPHAGAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 335 NEW ZEALAND ESOPHAGAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 336 NEW ZEALAND LUNG IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 337 NEW ZEALAND LUNG IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 338 NEW ZEALAND BLADDER IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 339 NEW ZEALAND BLADDER IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 340 NEW ZEALAND CERVICAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 341 NEW ZEALAND CERVICAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 342 NEW ZEALAND PROSTATE IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 343 NEW ZEALAND PROSTATE IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 344 NEW ZEALAND CANCER PHOTODYNAMIC THERAPY MARKET, BY THERAPY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 345 NEW ZEALAND CANCER PHOTODYNAMIC THERAPY MARKET, BY PROCEDURE TECHNIQUE, 2018-2032 (USD THOUSAND)
TABLE 346 NEW ZEALAND CANCER PHOTODYNAMIC THERAPY MARKET, BY DISEASE STAGE, 2018-2032 (USD THOUSAND)
TABLE 347 NEW ZEALAND CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 348 NEW ZEALAND CANCER PHOTODYNAMIC THERAPY MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 349 NEW ZEALAND HOSPITALS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 350 NEW ZEALAND HOSPITALS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY SIZE, 2018-2032 (USD THOUSAND)
TABLE 351 NEW ZEALAND CANCER PHOTODYNAMIC THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 352 SINGAPORE CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 353 SINGAPORE PHOTOSENSITIZER DRUGS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY CLASS, 2018-2032 (USD THOUSAND)
TABLE 354 SINGAPORE PHOTOSENSITIZER DRUGS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY FORMULATION, 2018-2032 (USD THOUSAND)
TABLE 355 SINGAPORE PHOTODYNAMIC THERAPY DEVICES IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 356 SINGAPORE LIGHT DELIVERY SYSTEMS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 357 SINGAPORE ACCESSORIES & CONSUMABLES IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 358 SINGAPORE CANCER PHOTODYNAMIC THERAPY MARKET, BY CANCER INDICATION, 2018-2032 (USD THOUSAND)
TABLE 359 SINGAPORE SKIN & CUTANEOUS ONCOLOGY IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 360 SINGAPORE SKIN & CUTANEOUS ONCOLOGY IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 361 SINGAPORE HEAD & NECK IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 362 SINGAPORE HEAD & NECK IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 363 SINGAPORE ESOPHAGAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 364 SINGAPORE ESOPHAGAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 365 SINGAPORE LUNG IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 366 SINGAPORE LUNG IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 367 SINGAPORE BLADDER IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 368 SINGAPORE BLADDER IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 369 SINGAPORE CERVICAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 370 SINGAPORE CERVICAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 371 SINGAPORE PROSTATE IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 372 SINGAPORE PROSTATE IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 373 SINGAPORE CANCER PHOTODYNAMIC THERAPY MARKET, BY THERAPY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 374 SINGAPORE CANCER PHOTODYNAMIC THERAPY MARKET, BY PROCEDURE TECHNIQUE, 2018-2032 (USD THOUSAND)
TABLE 375 SINGAPORE CANCER PHOTODYNAMIC THERAPY MARKET, BY DISEASE STAGE, 2018-2032 (USD THOUSAND)
TABLE 376 SINGAPORE CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 377 SINGAPORE CANCER PHOTODYNAMIC THERAPY MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 378 SINGAPORE HOSPITALS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 379 SINGAPORE HOSPITALS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY SIZE, 2018-2032 (USD THOUSAND)
TABLE 380 SINGAPORE CANCER PHOTODYNAMIC THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 381 PHILIPPINES CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 382 PHILIPPINES PHOTOSENSITIZER DRUGS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY CLASS, 2018-2032 (USD THOUSAND)
TABLE 383 PHILIPPINES PHOTOSENSITIZER DRUGS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY FORMULATION, 2018-2032 (USD THOUSAND)
TABLE 384 PHILIPPINES PHOTODYNAMIC THERAPY DEVICES IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 385 PHILIPPINES LIGHT DELIVERY SYSTEMS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 386 PHILIPPINES ACCESSORIES & CONSUMABLES IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 387 PHILIPPINES CANCER PHOTODYNAMIC THERAPY MARKET, BY CANCER INDICATION, 2018-2032 (USD THOUSAND)
TABLE 388 PHILIPPINES SKIN & CUTANEOUS ONCOLOGY IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 389 PHILIPPINES SKIN & CUTANEOUS ONCOLOGY IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 390 PHILIPPINES HEAD & NECK IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 391 PHILIPPINES HEAD & NECK IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 392 PHILIPPINES ESOPHAGAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 393 PHILIPPINES ESOPHAGAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 394 PHILIPPINES LUNG IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 395 PHILIPPINES LUNG IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 396 PHILIPPINES BLADDER IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 397 PHILIPPINES BLADDER IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 398 PHILIPPINES CERVICAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 399 PHILIPPINES CERVICAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 400 PHILIPPINES PROSTATE IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 401 PHILIPPINES PROSTATE IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 402 PHILIPPINES CANCER PHOTODYNAMIC THERAPY MARKET, BY THERAPY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 403 PHILIPPINES CANCER PHOTODYNAMIC THERAPY MARKET, BY PROCEDURE TECHNIQUE, 2018-2032 (USD THOUSAND)
TABLE 404 PHILIPPINES CANCER PHOTODYNAMIC THERAPY MARKET, BY DISEASE STAGE, 2018-2032 (USD THOUSAND)
TABLE 405 PHILIPPINES CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 406 PHILIPPINES CANCER PHOTODYNAMIC THERAPY MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 407 PHILIPPINES HOSPITALS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 408 PHILIPPINES HOSPITALS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY SIZE, 2018-2032 (USD THOUSAND)
TABLE 409 PHILIPPINES CANCER PHOTODYNAMIC THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 410 THAILAND CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 411 THAILAND PHOTOSENSITIZER DRUGS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY CLASS, 2018-2032 (USD THOUSAND)
TABLE 412 THAILAND PHOTOSENSITIZER DRUGS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY FORMULATION, 2018-2032 (USD THOUSAND)
TABLE 413 THAILAND PHOTODYNAMIC THERAPY DEVICES IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 414 THAILAND LIGHT DELIVERY SYSTEMS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 415 THAILAND ACCESSORIES & CONSUMABLES IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 416 THAILAND CANCER PHOTODYNAMIC THERAPY MARKET, BY CANCER INDICATION, 2018-2032 (USD THOUSAND)
TABLE 417 THAILAND SKIN & CUTANEOUS ONCOLOGY IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 418 THAILAND SKIN & CUTANEOUS ONCOLOGY IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 419 THAILAND HEAD & NECK IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 420 THAILAND HEAD & NECK IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 421 THAILAND ESOPHAGAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 422 THAILAND ESOPHAGAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 423 THAILAND LUNG IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 424 THAILAND LUNG IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 425 THAILAND BLADDER IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 426 THAILAND BLADDER IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 427 THAILAND CERVICAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 428 THAILAND CERVICAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 429 THAILAND PROSTATE IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 430 THAILAND PROSTATE IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 431 THAILAND CANCER PHOTODYNAMIC THERAPY MARKET, BY THERAPY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 432 THAILAND CANCER PHOTODYNAMIC THERAPY MARKET, BY PROCEDURE TECHNIQUE, 2018-2032 (USD THOUSAND)
TABLE 433 THAILAND CANCER PHOTODYNAMIC THERAPY MARKET, BY DISEASE STAGE, 2018-2032 (USD THOUSAND)
TABLE 434 THAILAND CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 435 THAILAND CANCER PHOTODYNAMIC THERAPY MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 436 THAILAND HOSPITALS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 437 THAILAND HOSPITALS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY SIZE, 2018-2032 (USD THOUSAND)
TABLE 438 THAILAND CANCER PHOTODYNAMIC THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 439 MALAYSIA CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 440 MALAYSIA PHOTOSENSITIZER DRUGS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY CLASS, 2018-2032 (USD THOUSAND)
TABLE 441 MALAYSIA PHOTOSENSITIZER DRUGS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY FORMULATION, 2018-2032 (USD THOUSAND)
TABLE 442 MALAYSIA PHOTODYNAMIC THERAPY DEVICES IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 443 MALAYSIA LIGHT DELIVERY SYSTEMS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 444 MALAYSIA ACCESSORIES & CONSUMABLES IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 445 MALAYSIA CANCER PHOTODYNAMIC THERAPY MARKET, BY CANCER INDICATION, 2018-2032 (USD THOUSAND)
TABLE 446 MALAYSIA SKIN & CUTANEOUS ONCOLOGY IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 447 MALAYSIA SKIN & CUTANEOUS ONCOLOGY IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 448 MALAYSIA HEAD & NECK IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 449 MALAYSIA HEAD & NECK IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 450 MALAYSIA ESOPHAGAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 451 MALAYSIA ESOPHAGAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 452 MALAYSIA LUNG IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 453 MALAYSIA LUNG IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 454 MALAYSIA BLADDER IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 455 MALAYSIA BLADDER IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 456 MALAYSIA CERVICAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 457 MALAYSIA CERVICAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 458 MALAYSIA PROSTATE IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 459 MALAYSIA PROSTATE IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 460 MALAYSIA CANCER PHOTODYNAMIC THERAPY MARKET, BY THERAPY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 461 MALAYSIA CANCER PHOTODYNAMIC THERAPY MARKET, BY PROCEDURE TECHNIQUE, 2018-2032 (USD THOUSAND)
TABLE 462 MALAYSIA CANCER PHOTODYNAMIC THERAPY MARKET, BY DISEASE STAGE, 2018-2032 (USD THOUSAND)
TABLE 463 MALAYSIA CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 464 MALAYSIA CANCER PHOTODYNAMIC THERAPY MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 465 MALAYSIA HOSPITALS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 466 MALAYSIA HOSPITALS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY SIZE, 2018-2032 (USD THOUSAND)
TABLE 467 MALAYSIA CANCER PHOTODYNAMIC THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 468 REST OF ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
図表一覧
FIGURE 1 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET: SEGMENTATION
FIGURE 2 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET: DATA TRIANGULATION
FIGURE 3 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET: DROC ANALYSIS
FIGURE 4 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET: ASIA-PACIFIC VS REGIONAL ANALYSIS
FIGURE 5 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET: DBMR MARKET POSITION GRID
FIGURE 8 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET: MARKET END USER COVERAGE GRID
FIGURE 9 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET: SEGMENTATION
FIGURE 10 EXECUTIVE SUMMARY
FIGURE 11 STRATEGIC DECISIONS
FIGURE 12 TWO SEGMENTS COMPRISE THE ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE (2024)
FIGURE 13 INCREASING PREVALENCE OF CANCER ACROSS GLOBE EXPECTED TO DRIVE THE ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET IN THE FORECAST PERIOD OF 2025 TO 2032
FIGURE 14 PHOTOSENSITIZER DRUGS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET IN 2025 & 2032
FIGURE 15 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET-MARKET OVERVIEW
FIGURE 16 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2024
FIGURE 17 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2024
FIGURE 18 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032
FIGURE 19 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032
FIGURE 20 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET, BY CANCER INDICATION, 2024
FIGURE 21 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET, BY CANCER INDICATION, 2024
FIGURE 22 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET, BY CANCER INDICATION, 2018-2032
FIGURE 23 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET, BY CANCER INDICATION, 2018-2032
FIGURE 24 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET, BY THERAPY MODALITY, 2024
FIGURE 25 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET, BY THERAPY MODALITY, 2024
FIGURE 26 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET, BY THERAPY MODALITY, 2018-2032
FIGURE 27 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET, BY THERAPY MODALITY, 2018-2032
FIGURE 28 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET, BY PROCEDURE TECHNIQUE, 2024
FIGURE 29 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET, BY PROCEDURE TECHNIQUE, 2024
FIGURE 30 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET, BY PROCEDURE TECHNIQUE, 2018-2032
FIGURE 31 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET, BY PROCEDURE TECHNIQUE, 2018-2032
FIGURE 32 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET, BY DISEASE STAGE, 2024
FIGURE 33 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET, BY DISEASE STAGE, 2024
FIGURE 34 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET, BY DISEASE STAGE, 2018-2032
FIGURE 35 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET, BY DISEASE STAGE, 2018-2032
FIGURE 36 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2024
FIGURE 37 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032
FIGURE 38 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032
FIGURE 39 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032
FIGURE 40 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET, BY END USER, 2024
FIGURE 41 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET, BY END USER, 2024
FIGURE 42 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET, BY END USER, 2018-2032
FIGURE 43 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET, BY END USER, 2018-2032
FIGURE 44 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2024
FIGURE 45 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2024
FIGURE 46 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032
FIGURE 47 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032
FIGURE 48 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET: SNAPSHOT (2024)
FIGURE 49 ASIA-PACIFIC CANCER PHOTODYNAMIC THERAPY MARKET: COMPANY SHARE 2024 (%)
調査方法
データ収集と基準年分析は、大規模なサンプル サイズのデータ収集モジュールを使用して行われます。この段階では、さまざまなソースと戦略を通じて市場情報または関連データを取得します。過去に取得したすべてのデータを事前に調査および計画することも含まれます。また、さまざまな情報ソース間で見られる情報の不一致の調査も含まれます。市場データは、市場統計モデルと一貫性モデルを使用して分析および推定されます。また、市場シェア分析と主要トレンド分析は、市場レポートの主要な成功要因です。詳細については、アナリストへの電話をリクエストするか、お問い合わせをドロップダウンしてください。
DBMR 調査チームが使用する主要な調査方法は、データ マイニング、データ変数が市場に与える影響の分析、および一次 (業界の専門家) 検証を含むデータ三角測量です。データ モデルには、ベンダー ポジショニング グリッド、市場タイムライン分析、市場概要とガイド、企業ポジショニング グリッド、特許分析、価格分析、企業市場シェア分析、測定基準、グローバルと地域、ベンダー シェア分析が含まれます。調査方法について詳しくは、お問い合わせフォームから当社の業界専門家にご相談ください。
カスタマイズ可能
Data Bridge Market Research は、高度な形成的調査のリーダーです。当社は、既存および新規のお客様に、お客様の目標に合致し、それに適したデータと分析を提供することに誇りを持っています。レポートは、対象ブランドの価格動向分析、追加国の市場理解 (国のリストをお問い合わせください)、臨床試験結果データ、文献レビュー、リファービッシュ市場および製品ベース分析を含めるようにカスタマイズできます。対象競合他社の市場分析は、技術ベースの分析から市場ポートフォリオ戦略まで分析できます。必要な競合他社のデータを、必要な形式とデータ スタイルでいくつでも追加できます。当社のアナリスト チームは、粗い生の Excel ファイル ピボット テーブル (ファクト ブック) でデータを提供したり、レポートで利用可能なデータ セットからプレゼンテーションを作成するお手伝いをしたりすることもできます。
